Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease

被引:17
作者
Moat, SJ
Bonham, JR
Powers, HJ [1 ]
机构
[1] Univ Sheffield, No Gen Hosp, Div Clin Sci, Ctr Human Nutr, Sheffield S5 7AU, S Yorkshire, England
[2] Sheffield Childrens Hosp, Dept Paediat Chem Pathol, Sheffield S10 2TH, S Yorkshire, England
[3] Sheffield Childrens Hosp, Dept Neonatal Screening, Sheffield S10 2TH, S Yorkshire, England
[4] Univ Sheffield, No Gen Hosp, Div Child Hlth, Sheffield S5 7AU, S Yorkshire, England
关键词
antioxidants; cardiovascular disease; cysteine; hyperhomocysteinaemia; oxidant stress;
D O I
10.1042/CS20000152
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hyperhomocysteinaemia is considered to be an independent risk factor for vascular disease. Elevated plasma homocysteine may pose an oxidative stress, leading to the development of vascular damage. A component of this effect may be a disturbance of the extracellular aminothiol redox state. The relative contributions of plasma total homocysteine (tHcy) and plasma total cysteine (tCys) to the total antioxidant capacity (TAOC) of plasma was established in subjects with normal and elevated plasma tHcy. A total of 10 subjects with severe hyperhomocysteinaemia (due to inherited metabolic defects), 13 of their heterozygous parents and 72 normal healthy subjects were recruited to the study. The mean plasma tHcy in the patients was 91.8 mu mol/l, compared with 13.2 mu mol/l in the parents and 14.7 mu mol/l in healthy control subjects. Plasma tCys and plasma TAOC were significantly lower in the subjects with severe hyperhomocysteinaemia compared with the parents and healthy control subjects (P < 0.05). In blood samples from subjects with a normal tHcy, a positive correlation was observed between tCys and tHcy (P = 0.0001). In contrast, in blood samples with tHcy <greater than or equal to> 20 mu mol/l, plasma tCys was negatively correlated with tHcy (P = 0.0001). In samples with tHcy greater than or equal to 20 mu mol/l, tHcy was inversely correlated with TAOC (P = 0.0001), whereas tCys was positively associated with TAOC (P = 0.0001). Multiple regression analysis revealed that tCys was the most important independent determinant of TAOC in the patient and control groups when the effects of tHcy and several factors known to influence TAOC, such as urate, were taken into account. Thus hyperhomocysteinaemia may pose an oxidative stress not only through the direct cytotoxicity of homocysteine, but also from an associated fall in plasma cysteine.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 34 条
[1]   Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults [J].
Bellamy, MF ;
McDowell, IFW ;
Ramsey, MW ;
Brownlee, M ;
Bones, C ;
Newcombe, RG ;
Lewis, MJ .
CIRCULATION, 1998, 98 (18) :1848-1852
[2]   ANTIOXIDANTS, VON-WILLEBRAND-FACTOR AND ENDOTHELIAL-CELL INJURY IN HYPERCHOLESTEROLEMIA AND VASCULAR-DISEASE [J].
BLANN, AD ;
MAXWELL, SRJ ;
BURROWS, G ;
MILLER, JP .
ATHEROSCLEROSIS, 1995, 116 (02) :191-198
[3]   Homocysteine mediated endothelial cell toxicity and its amelioration [J].
Blundell, G ;
Jones, BG ;
Rose, FA ;
Tudball, N .
ATHEROSCLEROSIS, 1996, 122 (02) :163-172
[4]  
Bonham J. R., 1998, Journal of Inherited Metabolic Disease, V21, P2
[5]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[6]   IMPAIRED ENDOTHELIAL FUNCTION OCCURS IN THE SYSTEMIC ARTERIES OF CHILDREN WITH HOMOZYGOUS HOMOCYSTINURIA BUT NOT IN THEIR HETEROZYGOUS PARENTS [J].
CELERMAJER, DS ;
SORENSEN, K ;
RYALLS, M ;
ROBINSON, J ;
THOMAS, O ;
LEONARD, JV ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :854-858
[7]   Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia - An effect reversible with vitamin C therapy [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Obeid, OA ;
Kooner, JS .
CIRCULATION, 1999, 99 (09) :1156-1160
[8]  
Cobbaert C, 1997, CLIN CHEM, V43, P1958
[9]  
El-Khairy L, 1999, AM J CLIN NUTR, V70, P1016
[10]   Cysteine is a cardiovascular risk factor in hyperlipidemic patients [J].
Jacob, N ;
Bruckert, E ;
Giral, P ;
Foglietti, MJ ;
Turpin, G .
ATHEROSCLEROSIS, 1999, 146 (01) :53-59